News

Omicron is coming! What to do with the new crown nucleic acid rapid test?

Author: Site Editor Publish Time: 2020-04-07 Origin: Site


Previously, I wrote in other articles about a new coronavirus in South Africa is raging has begun to sweep through the countries around South Africa, the United Kingdom and other countries are inevitable. Just less than a week later, Omicron has been included in the VOC list (Variant of Concern) by the WHO and has already spread in Hong Kong, China, with a number of people being infected with Omicron virus by the new coronavirus rapid detection.

 

First, let's talk about what is Omicron virus?

 

Omicron is a new coronavirus variant, World Health Organization number B.1.1.529, first discovered on the African continent on November 9, 2021. It is distinguished from other mutant strains by the number of genomic variants. More than 50 mutations have been found in the Omicron genome, and more than 30 mutations have been found in the S-protein (stinger protein), including more than 10 mutations in the RBD region of the ACE2 receptor, which is far more than the Delta mutant, the dominant neo-coronavirus strain worldwide, and is the It is the most mutated neo-coronavirus strain to date. Based on previous experience in the fight against the epidemic, these changes in the new mutant strain Omicron may strengthen its ability to break through the body's immune defense system, i.e., immune escape.

 

Although this mutant strain has not yet achieved transmission in the mainland, its ability to spread has still attracted the attention of the Health and Welfare Commission, and several domestic manufacturers have tested the new crown nucleic acid rapid test products and issued valid statements.

 

So how is the new crown nucleic acid rapid test to deal with this virus?

 

First, the new crown nucleic acid rapid test equipment needs to the upgrade! The so-called new crown nucleic acid rapid test equipment is undoubtedly the new crown nucleic acid rapid test reagents and new crown nucleic acid rapid test instrument. The number of mutations of this virus reached 50, although the new crown nucleic acid rapid test reagents currently on the market have also been proven to be effective in dealing with O mutant strains, but this also indicates the direction of the future epidemic development trend: the new crown strains may occur more powerful mutations.

 

Therefore, each manufacturer can not stop the research and development of their own reagents, I heard that some manufacturers of new crown nucleic acid rapid test reagent development has been on the agenda, the third generation of new crown nucleic acid rapid test reagents have been on the road, more accurate, more sensitive reagents are the future competitiveness!

 

 

Secondly, the new crown nucleic acid rapid test instruments also need to be constantly upgraded, to achieve stronger automation is the future trend is certain. The more infectious new crown virus is undoubtedly a challenge to the protection of the test personnel and upgrade, how to protect the new crown nucleic acid rapid test personnel at the same time, effectively improve the efficiency of the new crown nucleic acid rapid test, effectively improve the convenience of the new crown nucleic acid rapid test has become the future competitiveness of the instrument. New crown nucleic acid rapid test automatic all-in-one machine is the backbone of the future!

 

 

In the current new crown nucleic acid rapid test reagents and new crown nucleic acid rapid test equipment has not yet been developed, we do not need to worry, the current new crown nucleic acid rapid test reagents have been confirmed to be able to effectively detect the virus, that is, the specific fragment of the virus nucleic acid still has the recognition function.

 

 

The current preventive and control measures are still effective against the variant strain of Omicron. "Everyone can effectively prevent infection by actively vaccinating against the new coronavirus, while following the four measures and eight precautions we have proposed.

×

Contact Us

captcha
×

Inquire

*Name
*Email
Company Name
Tel
*Message